VR Logo

Unrated

SBI Healthcare Opportunities Fund


1 Lakh

Investment Grown to
₹ 1.53 Lakh

₹ 10000

Monthly SIP Grown to
₹ 5.74 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 2.94 -0.92 -0.65 5.56 13.85 35.73 65.77 15.14 7.96 14.58 16.23
S&P BSE Healthcare TRI 1.63 -1.19 -1.13 4.24 12.18 31.94 60.96 14.65 7.76 12.23 13.76
Equity: Sectoral-Pharma 1.44 -1.15 -1.26 4.25 12.11 33.71 64.29 18.06 10.13 14.95 15.37
Rank within category 1 1 1 1 1 2 5 4 4 2 2
Number of funds in category 9 9 9 9 9 9 9 4 4 3 3

As on 15-Jan-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 65.77 15.14 7.96 2.26 1,575
Nippon India Pharma Fund
Unrated
Jun-04 66.18 21.48 13.12 2.02 4,383
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 69.04 -- -- 2.37 2,159
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 68.85 -- -- 2.16 1,210
DSP Healthcare Fund - Regular Plan  | Invest Online
Unrated
Nov-18 73.16 -- -- 2.26 1,043

Best & Worst Performance

Best (Period) Worst (Period)
Week 19.09 (01-Apr-2020 - 09-Apr-2020) -21.04 (20-Oct-2008 - 27-Oct-2008)
Month 35.97 (05-May-2009 - 04-Jun-2009) -33.77 (01-Oct-2008 - 31-Oct-2008)
Quarter 74.69 (12-Mar-2009 - 11-Jun-2009) -44.39 (02-Sep-2008 - 02-Dec-2008)
Year 162.88 (07-May-2003 - 06-May-2004) -51.81 (12-Mar-2008 - 12-Mar-2009)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 15.56 22.05 0.49 0.96 0.90 0.63
S&P BSE Healthcare TRI 16.08 23.83 0.47 1.15 -- --
Equity: Sectoral-Pharma 18.28 21.26 0.64 1.35 0.87 3.67
Rank within category 4 4 4 4 3 4
Number of funds in category 4 4 4 4 4 4

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Dec-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 22
Top 10 Stocks (%) 71.81
Top 5 Stocks (%) 47.09
Top 3 Sectors (%) 98.88
Portfolio P/B Ratio 4.56
Portfolio P/E Ratio 38.80

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 33,962 39,267
Giant (%) 10.30 10.73
Large (%) 46.38 46.98
Mid (%) 26.74 32.97
Small (%) 16.58 9.32
Tiny (%) -- 0.09

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Sun Pharmaceutical Inds. Healthcare 98.55 14.48 4.95 10.15
equal Dr. Reddy's Lab Healthcare 53.82 10.86 0.00 9.91
equal Lupin Healthcare -- 10.14 0.00 9.30
down Cipla Healthcare 36.09 10.25 2.05 8.95
down Divi's Laboratories Healthcare 54.98 11.41 5.42 8.78
down Aurobindo Pharma Healthcare 17.46 11.32 0.00 8.77
equal Narayana Hrudayalaya Healthcare -- 4.55 0.00 4.55
down Strides Pharma Science Healthcare 109.35 9.29 3.40 4.18
up Alkem Laboratories Healthcare 25.33 6.59 0.00 3.72
up Abbott India Healthcare 48.38 7.11 0.00 3.50
up Ajanta Pharma Healthcare 27.25 4.64 0.00 3.08
equal Apollo Hospitals Healthcare 220.41 3.30 0.00 3.06
down Sequent Scientific Healthcare 66.15 3.22 1.36 3.01
down Gufic Biosciences Healthcare 79.20 5.17 1.75 2.76
down Natco Pharma Healthcare 37.95 3.91 0.00 2.44
down Solara Active Pharma Sciences Healthcare 27.73 2.52 0.00 2.27
down Thyrocare Technologies Healthcare 72.95 3.57 0.00 2.18
down Gland Pharma Healthcare 50.13 3.16 0.00 2.08
down Alembic Pharmaceuticals Healthcare 20.09 4.96 1.87 1.97
equal Pfizer Healthcare 46.99 4.24 0.00 1.95
up JB Chemicals & Pharma Healthcare 26.00 1.94 0.00 1.94
equal Shreno Construction -- 0.68 0.00 0.33

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Dec-2020

Fund Manager

— Tanmaya Desai since 27-Jun-2011

Education: Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).

Experience: Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.

Interviews:


-0.92%

Change from previous, NAV as on 15-Jan-2021

Growth: ₹ 202.5154

Dividend: ₹ 127.5719


Investment Strategy

The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) 1,000
Exit Load 0.5% for redemption within 15 days

Basic Details

Fund House: SBI Mutual Fund
Launch Date: 05-Jul-1999
Return Since Launch: 16.37%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 1,575 Cr (As on 31-Dec-2020)
Expense: 2.26% (As on 30-Nov-2020)
Risk Grade: --
Return Grade: --
Turnover: 69.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
Dividend16-Mar-201814.1000

 30-Jan-201510.0000
 31-Dec-20043.9000
 03-Sep-20043.0000
 19-Sep-20031.2000
Growth03-Sep-20043.0000

 19-Sep-20031.2000

Contact Information

AMC: SBI Funds Management Ltd

Address: 9th Floor-Crescenzo, C-38 & 39- G Block, Bandra-Kurla Complex, Bandra (East) Mumbai - 400051

Phone: 022-61793000 / 1800-425-5425

Fax: 022-22189663

Email: [email protected]

Website: http://www.sbimf.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

VR Helpline

Will this bull run continue?

dateSaturday, 23-Jan-2021
time04:00 PM - 04:30 PM